mutat
mevalon
kinas
mvk
thought
account
case
hyperimmunoglobulinemia
syndrom
hid
recurr
fever
howev
mechan
relationship
elev
serum
immunoglobulin
igd
clinic
featur
hid
unclear
studi
gener
fusion
pcr
vector
express
high
level
chimer
secretori
igd
csigd
specif
liver
gener
seven
founder
line
transgen
mice
comicroinject
verifi
use
genom
pcr
southern
blot
detect
express
csigd
revers
transcript
pcr
quantit
pcr
western
blot
enzymelink
immunosorb
assay
demonstr
csigd
could
specif
stabli
express
liver
use
flow
cytometri
show
overexpress
csigd
bone
marrow
spleen
cell
effect
b
cell
develop
morpholog
anatom
observ
transgen
mice
reveal
skin
damag
hepatosplenomegali
nephromegali
transgen
mice
mice
patholog
section
show
high
level
cell
necrosi
proteinlik
sediment
liver
spleen
kidney
demonstr
genom
insert
site
transgen
disrupt
mvk
gene
mous
chromosom
transgen
mous
use
explor
pathogenesi
hid
sigd
liverspecif
express
vector
hid
mvk
wang
p
wei
z
g
yan
b
w
et
al
establish
transgen
mous
model
liverspecif
express
secretori
immunoglobulin
sci
hyperimmunoglobulinemia
syndrom
hid
also
call
receptorassoci
period
syndrom
etiocholanolon
fever
character
high
serum
level
immunoglobulin
igd
recurr
febril
attack
may
also
includ
arthriti
lymphadenopathi
hepatosplenomegali
skin
rash
origin
describ
patient
dutch
ancestri
van
der
meer
et
al
report
world
includ
japan
pathogenesi
unknown
effect
therapi
high
level
iga
tumor
necrosi
factor
alpha
found
sera
hid
patient
patient
hid
also
secret
larg
amount
proinflammatori
cytokin
interleukin
may
connect
low
level
isoprenoid
metabol
end
product
caus
lack
mevalon
kinas
mvk
drenth
et
al
obtain
sampl
patient
unaffect
member
famili
hid
origin
netherland
franc
unit
kingdom
spain
czech
republ
mvk
gene
missens
mutat
result
decreas
mvk
activ
identifi
reduc
mvk
activ
fibroblast
suggest
mvk
mutat
caus
hid
sinc
mvk
gene
mutat
delet
found
hid
patient
mvk
proteas
cytoplasm
particip
synthesi
cholesterol
nonsterol
isoprenoid
human
mvk
locat
chromosom
mutat
mvk
occur
homozyg
approxim
hid
patient
heterozyg
other
second
common
mutat
effect
delet
singl
mvk
allel
mice
report
hanger
et
al
author
report
significantli
increas
igd
level
trend
toward
higher
iga
level
mvk
sera
compar
mvk
litterm
sera
accompani
period
fever
hepatosplenomegali
moreov
ammouri
et
al
report
among
fifti
hid
patient
high
serum
igd
even
though
homozygot
composit
heterozygot
mvk
mutat
indic
secretori
igd
sigd
play
import
role
clinic
present
hid
function
sigd
unclear
although
report
combin
antigen
microorgan
product
earli
inflammatori
respons
patient
contact
dermat
sigd
could
induc
bone
marrow
cellsmainli
neutrophil
eosinophil
basophil
migrat
skin
sigd
bind
basophil
calciummobil
receptor
induc
antimicrobi
b
cellstimul
factor
igd
crosslink
sigd
import
immunecondit
molecul
interact
bind
partner
induc
cell
activ
organ
penetr
immun
activ
factor
releas
enhanc
immun
defens
howev
excess
activ
lead
inflamm
tissu
destruct
effect
level
increas
sigd
vari
among
hid
patient
relationship
among
sigd
mvk
inflammatori
respons
unclear
unknown
increas
sigd
mvk
mutat
could
caus
inflamm
explor
question
construct
transgen
mous
model
liverspecif
sigd
overexpress
genom
dna
extract
liver
tissu
kunm
white
mice
purchas
zoolog
depart
nation
famili
plan
institut
beij
china
albumin
alb
enhanc
alb
promot
amplifi
pcr
primer
mous
alb
enhanc
enalbf
aac
gcg
tat
ttg
aat
aca
cac
ttt
tgt
cat
enalbr
ttg
ttc
atc
cca
aag
tta
tca
atc
aaa
gca
primer
mous
alb
promot
palbf
ctt
tga
ttg
ata
act
ttg
gga
tga
aca
acc
palbr
agc
tag
ctg
cca
gag
gct
agt
ggg
gtt
underlin
sequenc
indic
mlu
nhe
site
respect
four
adenin
nucleotid
use
protect
restrict
enzym
site
enalbf
palbr
primer
use
amplifi
enpalb
fragment
fusion
pcr
total
rna
isol
use
trizol
tiangen
beij
china
spleen
tissu
kunm
white
mice
total
rna
use
firststrand
cdna
synthesi
mmlv
revers
transcriptas
promega
madison
wi
code
region
sigd
heavi
chain
constant
region
igdhc
kappa
chain
constant
region
kc
amplifi
cdna
igdhc
region
amplifi
use
primer
igdhcf
gtc
acc
gtc
tcc
tca
ggt
gat
aaa
aag
gaa
cct
igdhcr
tgc
ggc
cgc
tca
ggc
aag
ggc
agg
acc
kc
region
amplifi
use
primer
kcf
gct
cga
gat
caa
acg
ggc
tga
tgc
tgc
acc
kcr
tgc
ggc
cgc
cta
aca
ctc
att
cct
gtt
underlin
sequenc
indic
site
four
thymidin
use
protect
restrict
enzym
site
code
region
heavi
chain
variabl
region
igghv
kappa
chain
variabl
region
kv
human
monoclon
antibodi
hepat
viru
hav
amplifi
pcr
plasmid
save
laboratori
igghv
region
amplifi
use
primer
igghvf
tga
att
cag
cat
ggg
tga
caa
tga
cat
cca
igghvr
cct
ttt
tat
cac
ctg
agg
aga
cgg
tga
underlin
sequenc
indic
ecor
site
sequenc
bold
typefac
show
kozak
fragment
four
thymidin
use
protect
restrict
enzym
site
kv
region
amplifi
use
primer
igghvf
kvr
ggt
gca
gca
tca
gcc
cgt
ttg
atc
tcg
agc
chimer
c
sigdh
bp
ckappa
bp
amplifi
fusion
pcr
primer
csigdh
igghvf
igdhcr
primer
ckappa
igghvf
kcr
csigdh
ckappa
separ
clone
express
plasmid
digest
ecor
use
mlu
nhe
restrict
enzym
digest
two
express
vector
cmv
promot
replac
enpalb
result
plasmid
design
enpalbcsigdh
enpalbckappa
control
mous
alb
regulatori
sequenc
direct
gene
express
specif
liver
csigdh
fragment
ckappa
fragment
releas
plasmid
mlu
nae
digest
respect
fragment
contain
mous
enpalb
promot
ig
secretori
leader
either
csigdh
gene
ckappa
gene
follow
bovin
growth
hormon
bgh
poli
figur
two
fragment
purifi
agaros
gel
electrophoresi
omega
boston
massachusett
subsequ
comicroinject
molar
ratio
pronuclei
fertil
kunm
white
ova
accord
standard
protocol
genom
dna
extract
mous
tail
biopsi
presenc
transgen
verifi
pcr
primer
palbf
enpalbr
aag
gga
aga
aag
cga
primer
specif
alb
promot
bgh
poli
sequenc
respect
could
detect
heavi
light
chain
gene
simultan
genom
dna
digest
dra
analyz
southern
blot
digoxigeninlabel
hybrid
probe
probe
amplifi
product
csigdh
ckappa
gene
total
rna
extract
use
trizol
cwbio
beij
blood
orbit
sinu
transgen
nontransgen
mice
collect
centrifug
tube
store
overnight
serum
obtain
centrifug
min
store
total
serum
protein
concentr
determin
bca
method
beyotim
china
serum
sampl
contain
protein
mix
denatur
min
separ
sdspage
gel
reduc
condit
use
separ
sampl
stain
coomassi
brilliant
blue
western
blot
separ
protein
electrophoret
transfer
nitrocellulos
membran
amersham
pharmacia
uk
wash
twice
trisbuff
tween
tbst
min
incub
overnight
block
buffer
defat
milk
tbst
follow
two
wash
tbst
min
membran
incub
dilut
block
reagent
horseradish
peroxidaseconjug
monoclon
antimous
igd
antibodi
ebiosci
san
diego
california
h
room
temperatur
wash
three
time
min
visual
use
enhanc
chemiluminesc
reagent
amersham
bioscienc
uk
accord
manufactur
instruct
mous
gapdh
use
intern
control
detect
sigd
express
transgen
mous
liver
western
blot
mous
serum
igdelisa
kit
bluegen
china
brought
room
temperatur
min
use
accord
manufactur
instruct
one
hundr
microlit
serum
standard
sampl
distil
water
blank
ad
well
microtit
plate
enzymelink
marker
solut
ad
well
except
blank
well
well
cover
adhes
strip
incub
h
microtit
plate
wash
five
time
pat
dri
absorb
paper
next
chromogen
reagent
b
ad
well
except
blank
well
plate
incub
dark
min
follow
addit
stop
solut
well
optic
densiti
nm
well
determin
within
min
use
automat
micropl
reader
biorad
co
philadelphia
usa
isol
bone
marrow
cell
spleen
cell
transgen
mice
sexmatch
litterm
nontransgen
mice
sacrif
cervic
disloc
flesh
mous
leg
strip
ml
syring
fill
phosphatebuff
salin
pb
insert
bone
caviti
flush
bone
marrow
centrifug
tube
kept
ice
spleen
tissu
place
onto
siev
nanj
xiaoxiao
instrument
equip
co
ltd
sprinkl
small
amount
pb
gentli
broken
intact
singl
cell
core
syring
cell
flush
pb
centrifug
tube
kept
ice
two
volum
red
blood
cell
lysi
buffer
ebiosci
san
diego
california
ad
remov
red
blood
cell
mix
incub
ice
min
reaction
termin
ad
five
volum
pb
singlecel
suspens
bone
marrow
spleen
centrifug
min
supernat
discard
cell
resuspend
appropri
amount
pb
bone
marrow
spleen
cell
count
use
blood
cell
count
board
cell
divid
five
fraction
addit
antibodi
blank
antibodi
ad
phycoerythrinconjug
antimous
fluorescein
isothiocyanateconjug
antimous
igm
phycoerythrinconjug
antimous
three
antibodi
dilut
dosag
antibodi
accord
manufactur
instruct
ebiosci
san
diego
california
ten
tube
cell
five
bone
marrow
spleen
incub
dark
min
accord
manufactur
instruct
cell
wash
twice
pb
centrifug
min
resuspend
pb
kept
ice
b
cell
analyz
flow
cytometri
moflo
high
perform
cell
sorter
dako
fort
collin
colorado
three
transgenespecif
primer
cag
cac
cct
cac
caa
gag
cct
agc
cag
cca
tct
gtt
gag
gcg
gaa
aga
arbitrari
degener
primer
cga
swg
ana
wga
gna
gwa
nca
wag
gna
gwa
nca
nag
use
tailpcr
primari
pcr
reaction
contain
genom
dna
secondari
tertiari
amplif
first
secondari
product
use
templat
respect
product
tertiari
tailpcr
separ
agaros
gel
singl
band
mous
sampl
purifi
tiangel
midi
purif
kit
tiangen
china
sequenc
analyz
blast
nation
center
biotechnolog
inform
websit
addit
morpholog
anatomi
observ
tissu
section
stain
hematoxylineosin
analysi
transgen
mice
detect
nine
transgen
founder
no
obtain
mice
analyz
pcr
figur
carri
csigdh
ckappa
transgen
addit
anoth
three
founder
carri
either
csigdh
ckappa
transgen
analyz
southern
blot
use
confirm
transgen
integr
genom
nine
transgen
mice
figur
probe
specif
csigdh
ckappa
fragment
mix
togeth
allow
transgen
detect
simultan
founder
founder
die
founder
could
passag
ill
howev
mate
wildtyp
mice
transmit
transgen
offspr
f
transgen
mice
doubl
transgen
identifi
among
offspr
transgen
mrna
express
liver
tissu
transgen
mice
analyz
rtpcr
figur
csigdh
ckappa
transgen
express
eight
transgen
line
no
f
gener
six
mice
f
gener
band
neg
control
mice
band
housekeep
gene
visibl
bp
confirm
csigdh
express
chimer
mrna
liver
tissu
transgen
mice
quantit
pcr
show
differ
level
express
csigdh
ckappa
individu
mice
among
differ
mice
figur
serum
sampl
collect
five
transgen
founder
mice
f
mice
f
l
f
f
f
f
l
carri
transgen
express
serum
sigd
analyz
western
blot
singl
band
detect
sigdh
reduc
condit
expect
molecular
weight
kd
figur
express
sigd
liver
spleen
f
two
neg
litterm
analyz
singl
band
detect
tissu
mous
f
control
band
observ
spleen
liver
sigd
alway
express
spleen
liver
normal
condit
figur
elisa
serum
sigd
level
transgen
line
greater
control
mice
figur
bone
marrow
spleen
cell
randomli
select
transgen
mous
f
sexmatch
litterm
neg
control
analyz
flow
cytometri
signific
differ
content
prob
igm
preb
igm
immatur
b
igm
bone
marrow
cell
matur
spleen
b
cell
igd
igm
figur
dicat
sigd
overexpress
transgen
mice
effect
b
cell
develop
use
genom
walk
tailpcr
detect
site
integr
transgen
fragment
three
transgen
mice
f
l
f
f
l
data
shown
transgen
three
mice
integr
chromosom
respect
function
gene
near
insert
site
indic
mvk
locu
mous
chromosom
disrupt
transgen
observ
morpholog
anatomi
four
transgen
line
f
f
f
f
found
mice
skin
ulcer
hepatomegali
splenomegali
renomegali
liver
time
spleen
time
kidney
time
size
nontransgen
litterm
figur
hematoxylineosin
stain
tissu
section
show
organ
diseas
high
degre
cell
necrosi
fiberlik
protein
precipit
figur
four
transgen
founder
mate
wild
type
mice
f
f
could
passag
ill
f
two
posit
offspr
one
skin
ulcer
hepatosplenomegali
renomegali
two
three
posit
offspr
f
sigd
consid
function
consid
low
level
serum
short
halflif
recent
report
hid
caus
research
reexamin
sigd
specif
role
hid
still
clear
facilit
research
gener
mous
model
stabli
effici
express
sigd
studi
found
csigd
could
express
liver
mice
control
alb
enhanc
promot
mous
alb
promot
contain
six
cisact
element
bind
hepatocyt
nuclear
factor
ccaatbind
protein
dbind
protein
leucin
chlorolactamas
nuclear
factor
respect
thu
initi
gene
transcript
liver
addit
enhanc
locat
kb
upstream
increas
promot
activ
sigd
express
increas
differ
degre
individu
mice
mice
carri
transgen
transgen
founder
transmit
transgen
offspr
consist
previou
report
comicroinject
normal
lead
cointegr
two
transgen
singl
chromosom
site
express
sigd
show
gene
copi
number
directli
proport
level
gene
express
consist
previou
studi
indic
transgen
integr
site
reflect
gene
express
level
better
copi
number
delet
singl
mvk
allel
mous
abl
increas
sigd
compar
neg
control
mice
insert
target
gene
multipl
clone
site
construct
highexpress
sigd
transgen
mous
model
express
transgen
could
detect
rtpcr
heart
liver
spleen
lung
kidney
intestin
brain
muscl
data
shown
lack
increas
serum
sigd
may
one
three
follow
reason
first
variabl
region
csigd
deriv
human
rather
mous
may
affect
spatial
structur
molecul
result
affact
identif
antibodi
second
use
kappa
light
chain
construct
csigd
sigd
preferenti
use
lambda
light
chain
kappa
light
chain
use
membran
igd
might
also
affect
secret
detect
csigd
final
sigd
might
increas
serum
rapidli
degrad
protect
mechan
make
increas
undetect
studi
need
explain
achiev
stabl
effici
express
sigd
sigd
sign
earlystag
b
cell
activ
also
involv
product
mainten
memori
b
cell
may
play
import
role
sensit
respons
b
cell
toler
therefor
sigd
increas
b
cell
develop
affect
flow
cytometri
analysi
show
chang
proport
b
cell
variou
stage
develop
prob
preb
immatur
b
matur
b
transgen
control
mice
indic
transgen
affect
b
cell
develop
genom
walk
demonstr
transgen
integr
differ
chromosom
differ
transgen
mice
function
gene
includ
mvk
disrupt
indic
inflamm
transgen
mice
caus
increas
sigd
rather
mvk
mutat
sigd
proinflammatori
function
effect
induc
antimicrobi
immunostimul
proinflammatori
factor
mucos
igd
enhanc
local
immun
epitheli
transport
wherea
circul
igd
bind
basophil
calciummobil
receptor
addit
quickli
mediat
innat
immun
respons
igd
also
conduct
immun
signal
bacteria
invad
igdbound
basophil
encount
antigen
migrat
lymphoid
system
mucos
immun
lymphoid
organ
driven
chemokin
releas
mast
cell
igd
stimul
basophil
organ
calciummobil
receptor
induc
antimicrobi
opson
inflammatori
b
cellstimul
factor
enhanc
immun
protect
induc
extrem
immun
respons
lead
lesion
destruct
skin
ulcer
transgen
mice
high
express
sigd
may
caus
excess
immun
activ
addit
display
sever
hepatosplenomegali
renomegali
diseas
organ
high
degre
cell
necrosi
fiberlik
protein
precipit
similar
state
seen
human
hid
howev
studi
requir
prove
use
transgen
mice
model
hid
